Note: Ingredients listed on restricted chemical lists
EC/CAS
64742-49-0
Name of the chemical
Naphtha (petroleum), hydrotreated light
Concentration
N/A
General Information
Revision date
2024-01-15
Product name
MPM Wasbenzine
CAS No.
64742-49-0
REACH No
01-2119473851-33
1.2.1 Relevant identified uses
Professional use,Industrial use
Manufacturer Name
MPM International Oil Company BV
Emergency telephone
+31 (0)15 2514030, +353 1 809 2566, +353 1 809 2166, +44 20 7188 7188
Icons in SDS
Company Information
company name
MPM International Oil Company BV
e-mail address of the competent person responsible for the Safety Data Sheet
info@mpmoil.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H225, H304, H336, H411
Hazard statements
Code
Statements
H225
Highly Flammable liquid and vapour
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
No additional information available
2.2 Label elements
Labelling
Hazard pictograms
GHS02 GHS07 GHS08 GHS09
Signal word
Danger.
Hazard statements
H225 - Highly flammable liquid and vapour. H336 - May cause drowsiness or dizziness. H304 - May be fatal if swallowed and enters airways. H411 - Toxic to aquatic life with long lasting effects.
Precautionary statements
P210 - Keep away from Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking.. - No smoking. P243 - Take precautionary measures against static discharge. P273 - Avoid release to the environment. P280 - Wear eye protection, face protection. P285 - In case of inadequate ventilation wear respiratory protection. P301+P330+P331 - IF SWALLOWED: rinse mouth. Do NOT induce vomiting.
Supplemental label elements
EUH066 - Repeated exposure may cause skin dryness or cracking.
2.3 Other hazards
Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %
